Biotech Values

[corpstrat]

Repros never made a secret of its cash needs during 2007 or 2008, openly discussing burn and funding options on quarterly CCs and at webcast investor presentations, and predicting pretty much the funding arrangement that indeed occurred. The financing last fall was a near freaking miracle in that / this credit environment, when even a long like I am feared they'd have to shut things down.

But don't let substance get in the way of another FUD opportunity.